Skip to main content
Erschienen in: Updates in Surgery 2/2017

12.04.2017 | Review Article

Surgical management of papillary thyroid carcinoma: an overview

verfasst von: Paolo Miccoli, Sohail Bakkar

Erschienen in: Updates in Surgery | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The surgical management of papillary thyroid carcinoma remains contentious and the optimal surgical strategy has not been yet established. The extent of thyroid resection has been the nub of this debate. Literature lacks prospective randomized controlled trials that could help put this debate to rest, and these have been labeled as being impractical. Consequently, large retrospective studies and expert opinion have constituted the basis of clinical practice guidelines. Recent American Thyroid Association and National Comprehensive Cancer Network guidelines consider a conservative approach in the form of a thyroid lobectomy sufficient for low-risk disease and that total thyroidectomy remains the standard of care in the presence of high-risk features. Nevertheless, many authorities still advocate more aggressive therapy for low-risk disease. The challenge in standardizing the surgical strategy to papillary thyroid carcinoma is mainly related to a major tumor characteristic: the high frequency of occult cancerous foci whether within the thyroid gland itself or within loco-regional lymph nodes as this tumor characteristic has been incriminated for a higher risk of recurrent disease and its adverse sequelae. The purpose of this article is to provide an overview of the surgical management of papillary thyroid carcinoma and the main arguments surrounding this hotly debated topic. All evidences for this review article were drawn from PubMed articles in English language mostly cross-referenced with international guideline statements.
Literatur
3.
Zurück zum Zitat La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E (2015) Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136:2187–2195. doi:10.1002/ijc.29251 CrossRefPubMed La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E (2015) Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136:2187–2195. doi:10.​1002/​ijc.​29251 CrossRefPubMed
4.
Zurück zum Zitat Udelsman R, Lakatos E, Ladenson P (1996) Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88–93CrossRefPubMed Udelsman R, Lakatos E, Ladenson P (1996) Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88–93CrossRefPubMed
6.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, Doherty G, Mandel SJ, Nikiforov YE, Pacini F, Randolph G, Sawka A, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward D, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133. doi:10.1089/thy.2015.0020 CrossRefPubMedPubMedCentral Haugen BR, Alexander EK, Bible KC, Doherty G, Mandel SJ, Nikiforov YE, Pacini F, Randolph G, Sawka A, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward D, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133. doi:10.​1089/​thy.​2015.​0020 CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Haddad RI et al (2016) NCCN clinical practice guidelines in oncology (NCCN Guidelines®) for thyroid carcinoma version 1.2016. © 2016 National Comprehensive Cancer Network, Inc. http://NCCN.org Haddad RI et al (2016) NCCN clinical practice guidelines in oncology (NCCN Guidelines®) for thyroid carcinoma version 1.2016. © 2016 National Comprehensive Cancer Network, Inc. http://​NCCN.​org
8.
Zurück zum Zitat Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260:601–615CrossRefPubMedPubMedCentral Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260:601–615CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–381CrossRefPubMedPubMedCentral Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–381CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRef American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRef
11.
Zurück zum Zitat Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA (2015) Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab 100:115–121. doi:10.1210/jc.2014-3039 CrossRefPubMed Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA (2015) Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab 100:115–121. doi:10.​1210/​jc.​2014-3039 CrossRefPubMed
12.
Zurück zum Zitat Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer Staging Manual, 7th edn. Springer, New York Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer Staging Manual, 7th edn. Springer, New York
13.
Zurück zum Zitat Gyorki DE, Untch B, Tuttle RM, Shaha AR (2013) Prophylactic central neck dissection in differentiated thyroid cancer: an assessment of the evidence. Ann Surg Oncol 20:2285–2289CrossRefPubMed Gyorki DE, Untch B, Tuttle RM, Shaha AR (2013) Prophylactic central neck dissection in differentiated thyroid cancer: an assessment of the evidence. Ann Surg Oncol 20:2285–2289CrossRefPubMed
14.
Zurück zum Zitat Kim SH, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY (2016) Differences in the recurrence and survival of patients with symptomatic and asymptomatic papillary thyroid carcinoma: an observational study of 11,265 person-years of follow-up. Thyroid. 26:1472–1479CrossRefPubMed Kim SH, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY (2016) Differences in the recurrence and survival of patients with symptomatic and asymptomatic papillary thyroid carcinoma: an observational study of 11,265 person-years of follow-up. Thyroid. 26:1472–1479CrossRefPubMed
15.
Zurück zum Zitat Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMedPubMedCentral Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407PubMedPubMedCentral
16.
Zurück zum Zitat Grogan RH, Kaplan SP, Cao H, Weiss RE, Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL, Schechter RB (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436–1446. doi:10.1016/j.surg.2013.07.008 CrossRefPubMed Grogan RH, Kaplan SP, Cao H, Weiss RE, Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL, Schechter RB (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436–1446. doi:10.​1016/​j.​surg.​2013.​07.​008 CrossRefPubMed
17.
Zurück zum Zitat Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA (2015) Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol 33:2370–2375. doi:10.1200/JCO.2014.59.8391 CrossRefPubMed Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA (2015) Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol 33:2370–2375. doi:10.​1200/​JCO.​2014.​59.​8391 CrossRefPubMed
18.
Zurück zum Zitat Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–1216CrossRefPubMed Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–1216CrossRefPubMed
19.
Zurück zum Zitat Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330CrossRefPubMedPubMedCentral Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB (2001) Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 130:921–930CrossRefPubMed Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB (2001) Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 130:921–930CrossRefPubMed
22.
23.
Zurück zum Zitat Hirsch D, Levy S, Tsvetov G, Shimon I, Benbassat C (2014) Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma. Oncol Lett 7:849–853PubMed Hirsch D, Levy S, Tsvetov G, Shimon I, Benbassat C (2014) Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma. Oncol Lett 7:849–853PubMed
26.
Zurück zum Zitat Kluijfhout WP, Pasternak JD, Lim J, Kwon JS, Vriens MR, Clark OH, Shen WT, Gosnell JE, Suh I, Duh QY (2016) Frequency of high-risk characteristics requiring total thyroidectomy for 1–4 cm well-differentiated thyroid cancer. Thyroid 26:820–824. doi:10.1089/thy.2015.0495 CrossRefPubMed Kluijfhout WP, Pasternak JD, Lim J, Kwon JS, Vriens MR, Clark OH, Shen WT, Gosnell JE, Suh I, Duh QY (2016) Frequency of high-risk characteristics requiring total thyroidectomy for 1–4 cm well-differentiated thyroid cancer. Thyroid 26:820–824. doi:10.​1089/​thy.​2015.​0495 CrossRefPubMed
27.
Zurück zum Zitat Lang BH-H, Shek TWH, Wan KY (2016) The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1–4 cm: implications for completion thyroidectomy following lobectomy. Clin Endocrinol. doi:10.1111/cen.13165 Lang BH-H, Shek TWH, Wan KY (2016) The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1–4 cm: implications for completion thyroidectomy following lobectomy. Clin Endocrinol. doi:10.​1111/​cen.​13165
28.
Zurück zum Zitat Rosario PW, Mourão GF, Calsolari (2016) Apparently intrathyroid papillary thyroid carcinoma >1 and ≤4 cm: is the need for completion thyroidectomy common among patients submitted to lobectomy? Clin Endocrinol (Oxf) 85:150–151. doi:10.1111/cen.13034 CrossRef Rosario PW, Mourão GF, Calsolari (2016) Apparently intrathyroid papillary thyroid carcinoma >1 and ≤4 cm: is the need for completion thyroidectomy common among patients submitted to lobectomy? Clin Endocrinol (Oxf) 85:150–151. doi:10.​1111/​cen.​13034 CrossRef
29.
Zurück zum Zitat Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Shen WT, Gosnell JE, Suh I, Duh QY (2017) Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery 161:127–133. doi:10.1016/j.surg.2016.05.056 CrossRefPubMed Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Shen WT, Gosnell JE, Suh I, Duh QY (2017) Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery 161:127–133. doi:10.​1016/​j.​surg.​2016.​05.​056 CrossRefPubMed
30.
Zurück zum Zitat Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885CrossRefPubMed Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885CrossRefPubMed
31.
Zurück zum Zitat Sevim T (2007) Risk factors for permanent laryngeal nerve paralysis in patients with thyroid carcinoma. Clin Otolaryngol 32:378–383CrossRefPubMed Sevim T (2007) Risk factors for permanent laryngeal nerve paralysis in patients with thyroid carcinoma. Clin Otolaryngol 32:378–383CrossRefPubMed
32.
Zurück zum Zitat Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, Shah JP (2012) Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 151:571–579CrossRefPubMed Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, Shah JP (2012) Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 151:571–579CrossRefPubMed
33.
Zurück zum Zitat Ryu J, Ryu YM, Jung YS, Kim SJ, Lee YJ, Lee EK, Kim SK, Kim TS, Kim TH, Lee CY, Park SY, Chung KW (2013) Extent of thyroidectomy affects vocal and throat functions: a prospective observational study of lobectomy versus total thyroidectomy. Surgery 154:611–620. doi:10.1016/j.surg.2013.03.011 CrossRefPubMed Ryu J, Ryu YM, Jung YS, Kim SJ, Lee YJ, Lee EK, Kim SK, Kim TS, Kim TH, Lee CY, Park SY, Chung KW (2013) Extent of thyroidectomy affects vocal and throat functions: a prospective observational study of lobectomy versus total thyroidectomy. Surgery 154:611–620. doi:10.​1016/​j.​surg.​2013.​03.​011 CrossRefPubMed
34.
Zurück zum Zitat Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K (2014) Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg 38:68–79. doi:10.1007/s00268-013-2224-1 CrossRefPubMed Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K (2014) Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg 38:68–79. doi:10.​1007/​s00268-013-2224-1 CrossRefPubMed
35.
36.
Zurück zum Zitat Kwon H, Jeon MJ, Kim WG, Park S, Kim M, Song DE, Sung TY, Yoon JH, Hong SJ, Kim TY, Shong YK, Kim WB (2017) A comparison of lobectomy and total thyroidectomy for patients with papillary thyroid microcarcinoma: a retrospective individual risk factor matched cohort study. Eur J Endocrinol. doi:10.1530/EJE-16-0845 Kwon H, Jeon MJ, Kim WG, Park S, Kim M, Song DE, Sung TY, Yoon JH, Hong SJ, Kim TY, Shong YK, Kim WB (2017) A comparison of lobectomy and total thyroidectomy for patients with papillary thyroid microcarcinoma: a retrospective individual risk factor matched cohort study. Eur J Endocrinol. doi:10.​1530/​EJE-16-0845
37.
Zurück zum Zitat Kuba S, Yamanouchi K, Hayashida N, Maeda S, Adachi T, Sakimura C, Kawakami F, Yano H, Matsumoto M, Otsubo R, Sato S, Fujioka H, Kuroki T, Nagayasu T, Eguchi S (2016) Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: comparative analysis after propensity score matching: a multicenter study. Int J Surg. doi:10.1016/j.ijsu.2016.09.083 PubMed Kuba S, Yamanouchi K, Hayashida N, Maeda S, Adachi T, Sakimura C, Kawakami F, Yano H, Matsumoto M, Otsubo R, Sato S, Fujioka H, Kuroki T, Nagayasu T, Eguchi S (2016) Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: comparative analysis after propensity score matching: a multicenter study. Int J Surg. doi:10.​1016/​j.​ijsu.​2016.​09.​083 PubMed
38.
Zurück zum Zitat Kandil E, Krishnan B, Noureldine SI, Yao L, Tufano RP (2013) Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Otorhinolaryngol Relat Spec 75:6–17. doi:10.1159/000345498 CrossRefPubMed Kandil E, Krishnan B, Noureldine SI, Yao L, Tufano RP (2013) Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Otorhinolaryngol Relat Spec 75:6–17. doi:10.​1159/​000345498 CrossRefPubMed
39.
Zurück zum Zitat Li YJ, Wang YZ, Yi ZB, Chen LL, Zhou XD (2015) Comparison of completion thyroidectomy and primary total surgery for differentiated thyroid cancer: a meta-analysis. Oncol Res Treat 38:528–531. doi:10.1159/000440690 CrossRefPubMed Li YJ, Wang YZ, Yi ZB, Chen LL, Zhou XD (2015) Comparison of completion thyroidectomy and primary total surgery for differentiated thyroid cancer: a meta-analysis. Oncol Res Treat 38:528–531. doi:10.​1159/​000440690 CrossRefPubMed
40.
Zurück zum Zitat Leiker AJ, Yen TW, Cheung K, Evans DB, Wang TS (2013) Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of “suspicious for papillary thyroid cancer”. Surgery 154:1307–1313CrossRefPubMed Leiker AJ, Yen TW, Cheung K, Evans DB, Wang TS (2013) Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of “suspicious for papillary thyroid cancer”. Surgery 154:1307–1313CrossRefPubMed
41.
Zurück zum Zitat Corso C, Gomez X, Sanabria A, Vega V, Dominguez LC, Osorio C (2014) Total thyroidectomy versus hemithyroidectomy for patients with follicular neoplasm. A cost-utility analysis. Int J Surg 12:837–842CrossRefPubMed Corso C, Gomez X, Sanabria A, Vega V, Dominguez LC, Osorio C (2014) Total thyroidectomy versus hemithyroidectomy for patients with follicular neoplasm. A cost-utility analysis. Int J Surg 12:837–842CrossRefPubMed
42.
Zurück zum Zitat Schvartz C, Bonnetain F, Dabakuyo S, Gauthier M, Cueff A, Fieffé S, Pochart JM, Cochet I, Crevisy E, Dalac A, Papathanassiou D, Toubeau M (2012) Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab 97:1526–1535. doi:10.1210/jc.2011-2512 CrossRefPubMed Schvartz C, Bonnetain F, Dabakuyo S, Gauthier M, Cueff A, Fieffé S, Pochart JM, Cochet I, Crevisy E, Dalac A, Papathanassiou D, Toubeau M (2012) Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab 97:1526–1535. doi:10.​1210/​jc.​2011-2512 CrossRefPubMed
44.
Zurück zum Zitat Vaisman F, Momesso D, Bulzico DA, Pessoa CH, da Cruz MD, Dias F, Corbo R, Vaisman M, Tuttle RM (2013) Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res 2013:398194. doi:10.1155/2013/398194 CrossRefPubMedPubMedCentral Vaisman F, Momesso D, Bulzico DA, Pessoa CH, da Cruz MD, Dias F, Corbo R, Vaisman M, Tuttle RM (2013) Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res 2013:398194. doi:10.​1155/​2013/​398194 CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P, Torregrossa L, Sellari-Franceschini S, Basolo F, Vitti P, Elisei R, Miccoli P (2015) Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 100:1316–1324. doi:10.1210/jc.2014-3825 CrossRefPubMed Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P, Torregrossa L, Sellari-Franceschini S, Basolo F, Vitti P, Elisei R, Miccoli P (2015) Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 100:1316–1324. doi:10.​1210/​jc.​2014-3825 CrossRefPubMed
46.
Zurück zum Zitat Conzo G, Calò PG, Sinisi AA, De Bellis A, Pasquali D, Iorio S, Tartaglia E, Mauriello C, Gambardella C, Cavallo F, Medas F, Polistena A, Santini L, Avenia N (2014) Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: a retrospective study of a large clinical series. Surgery 155:998–1005. doi:10.1016/j.surg.2014.02.010 CrossRefPubMed Conzo G, Calò PG, Sinisi AA, De Bellis A, Pasquali D, Iorio S, Tartaglia E, Mauriello C, Gambardella C, Cavallo F, Medas F, Polistena A, Santini L, Avenia N (2014) Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: a retrospective study of a large clinical series. Surgery 155:998–1005. doi:10.​1016/​j.​surg.​2014.​02.​010 CrossRefPubMed
47.
Zurück zum Zitat Bardet S, Ciappuccini R, Quak E, Rame JP, Blanchard D, de Raucourt D, Babin E, Michels JJ, Vaur D, Heutte N (2015) Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer. J Clin Endocrinol Metab 100:132–140. doi:10.1210/jc.2014-1199 CrossRefPubMed Bardet S, Ciappuccini R, Quak E, Rame JP, Blanchard D, de Raucourt D, Babin E, Michels JJ, Vaur D, Heutte N (2015) Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer. J Clin Endocrinol Metab 100:132–140. doi:10.​1210/​jc.​2014-1199 CrossRefPubMed
48.
Zurück zum Zitat Hartl DM, Mamelle E, Borget I, Leboulleux S, Mirghani H, Schlumberger M (2013) Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg 37:1951–1958. doi:10.1007/s00268-013-2089-3 CrossRefPubMed Hartl DM, Mamelle E, Borget I, Leboulleux S, Mirghani H, Schlumberger M (2013) Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg 37:1951–1958. doi:10.​1007/​s00268-013-2089-3 CrossRefPubMed
49.
Zurück zum Zitat Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM, American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152. doi:10.1089/thy.2012.0043 CrossRefPubMed Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM, American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152. doi:10.​1089/​thy.​2012.​0043 CrossRefPubMed
50.
Zurück zum Zitat Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, Kloos RT, Mazzaferri EL Sr, Peduzzi PN, Roman SA, Sippel RS, Sosa JA, Stack BC Jr, Steward DL, Tufano RP, Tuttle RM, Udelsman R, American Thyroid Association Surgical Affairs Committee (2012) American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22:237–244. doi:10.1089/thy.2011.0317 CrossRefPubMed Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, Kloos RT, Mazzaferri EL Sr, Peduzzi PN, Roman SA, Sippel RS, Sosa JA, Stack BC Jr, Steward DL, Tufano RP, Tuttle RM, Udelsman R, American Thyroid Association Surgical Affairs Committee (2012) American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22:237–244. doi:10.​1089/​thy.​2011.​0317 CrossRefPubMed
Metadaten
Titel
Surgical management of papillary thyroid carcinoma: an overview
verfasst von
Paolo Miccoli
Sohail Bakkar
Publikationsdatum
12.04.2017
Verlag
Springer Milan
Erschienen in
Updates in Surgery / Ausgabe 2/2017
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-017-0449-5

Weitere Artikel der Ausgabe 2/2017

Updates in Surgery 2/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.